RPG Life Sciences Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 49,381 shares,. Its Average Traded Price (ATP) is ₹2920.54, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 4 @ ₹2940.60.
RPG Life Sciences has an upper circuit limit of ₹3528.70 and a lower circuit limit of ₹2352.50. The total value traded stands at ₹14.42 CR, and the delivery percentage for the day is 48.12%.
The stock is currently traded with a market lot size of 1. RPG Life Sciences also offers a dividend yield of 0.82%.
RPG Life Sciences Share Price Chart
RPG Life Sciences Share Key Metrics
Volume
49381.00
Market Cap
4863.46 CR
LTQ@LTP
4@2940.60
ATP
2920.54
Var Margin
20.88 %
Circuit Range
2352.5-3528.7
Delivery %
48.12 %
Value
14.42 CR
ASM/GSM
No
Market Lot
1
RPG Life Sciences Resistance and Support
Pivot 2814.2
Resistance
First Resistance
2864.3
Second Resistance
2950.1
Third Resistance
3000.2
Support
First Support
2728.4
Second Support
2678.3
Third Support
2592.5
RPG Life Sciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2024-25
- 2025-26
- 2022-23
- 2023-24
- 2026-27
Total Promoters
RPG Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-09 | 2026-07-09 | View More |
RPG Life Sciences News
RPG Life Sciences Ltd - 532983 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Clarus Trust has increased its shareholding in RPG Life Sciences by acquiring 37,463 shares (0.23% stake) from the open market. Following this transaction, the trust's total holding in the company has risen from 6.81% to 7.04%.
Sep 28 2026 14:13:01
RPG Life Sciences Ltd - 532983 - Intimation For Scheme Of Amalgamation
RPG Life Sciences' subsidiary RPG Active Pharma Limited (RPGAP) has approved a Scheme of Amalgamation with its wholly-owned subsidiary, Actis Generics Private Limited. This internal restructuring aims to streamline corporate structure, enhance operational efficiencies, and achieve cost savings.
Sep 26 2026 00:16:27
RPG Life Sciences Ltd - 532983 - Update On Share Purchase Agreement
RPG Life Sciences announced that its subsidiary, RPG Active Pharma Limited, has completed the acquisition of the entire stake in Actis Generics Private Limited. This transaction, effective September 24, 2026, makes Actis a wholly-owned subsidiary of RPGAP, enhancing the company's business presence.
Sep 24 2026 21:36:57
RPG Life Sciences Management
| Name | Position |
|---|---|
| Harsh Goenka | Chairman |
| Ashok Nair | Managing Director |
RPG Life Sciences Similar Stocks
FDC Ltd.
356.25
4.85 (1.38%)
Orchid Pharma Ltd.
911.25
-16.80 (1.81%)
Supriya Lifescience Ltd.
886.00
13.40 (1.54%)
Gujarat Themis Biosyn Ltd.
373.40
3.35 (0.91%)
Artemis Medicare Services Ltd.
306.35
3.35 (1.11%)
Gufic Biosciences Ltd.
404.50
-3.95 (0.97%)
SMS Pharmaceuticals Ltd.
450.50
25.55 (6.01%)
Indraprastha Medical Corporation Ltd.
320.05
-1.40 (0.44%)
Unichem Laboratories Ltd.
510.55
-10.65 (2.04%)
Aarti Drugs Ltd.
396.35
-0.10 (0.03%)
RPG Life Sciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in RPGLIFE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC